Zkusit zdarma
KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

KALV
Cena:
 
 
Valuace
70
Růst
60
Zdraví
75
preloader

Finanční výsledky KalVista Pharmaceuticals, Inc. (KALV)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-3.69-3.44-3.33-3.36-2.42
Gross Profit46M----
Net Income Attributable to Common Shareholders-183.4M-126.6M-92.9M-82.3M-46.2M
Operating Profit-112M-140.4M-110.9M-96.6M-57.9M
Total Revenues49.1M----